Zhong, M., van der Walt, A., Campagna, M. P., Stankovich, J., Butzkueven, H., & Jokubaitis, V. (2020). The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis. Neurotherapeutics.

Zhong, Michael, Anneke van der Walt, Maria Pia Campagna, Jim Stankovich, Helmut Butzkueven, and Vilija Jokubaitis. "The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis." Neurotherapeutics 2020.

Zhong, Michael, et al. "The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis." Neurotherapeutics 2020.